Are you Dr. Mularski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10180 Se Sunnyside Rd
Kaiser Sunnyside Medical Center - Pulmonary/Ccm
Clackamas, OR 97015Phone+1 503-652-2880Fax+1 503-335-6311- Is this information wrong?
Summary
- Dr. Richard Mularski, MD is a pulmonologist in Clackamas, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and California. He is affiliated with Kaiser Sunnyside Medical Center, Providence Portland Medical Center, and Legacy Salmon Creek Medical Center.
Education & Training
Oregon Health & Science UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002- Oregon Health & Science UniversityResidency, Internal Medicine, 1996 - 1999
University of Arizona College of MedicineClass of 1996
Certifications & Licensure
OR State Medical License 1997 - 2025
WA State Medical License 2006 - 2025
CA State Medical License 2002 - 2024- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function Start of enrollment: 2013 Jun 01
- Comparative Trial of Home-Based Palliative Care Start of enrollment: 2019 Jan 07
Publications & Presentations
PubMed
- Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak,...> ;Open Forum Infectious Diseases. 2023 Jun 1
- 2 citationsTemporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment ...Gail E Potter, Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R Rapaka, Sarah B Doernberg, David C Lye, Richard A Mularski, Noreen A Hynes, Susan Kline, Cath...> ;Annals of Internal Medicine. 2022 Dec 1
- 56 citationsBaricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.Wang, J. P., Wolfe, C., Tomashek, K., Patterson, T., Gomez, C., Marconi, V., Jain, M., Yang, O., Paules, C., Palacios, G., Grossberg, R., Harkins, M., Mularski, R., Er...> ;The Lancet. Respiratory Medicine. 2022 Sep 1
- Join now to see all
Press Mentions
FDA Approves Remdesivir for COVID Treatment Outside Hospital SettingsJanuary 31st, 2022
Comparative Clinical Effectiveness Research Focused on Community-Based Delivery of Palliative Care: Overview of the Patient-Centered Outcomes Research Institute's Funding InitiativeSeptember 1st, 2019
Promising Methods for Improving Quality Through the Faster Spread of Best PracticesApril 19th, 2019- Join now to see all
Grant Support
- Concert-Clinical Effectiveness Research (Concert-Cer)National Heart, Lung, And Blood Institute2009–2010
Professional Memberships
- Member
Hospital Affiliations
Kaiser Sunnyside Medical CenterClackamas, Oregon
Providence Portland Medical CenterPortland, Oregon
Legacy Salmon Creek Medical CenterVancouver, Washington
